26 November 2024
CVS Group
plc
("CVS" or
the "Company")
Grant of Options under CVS Group plc
SAYE Option Scheme &
PDMR Dealing
CVS Group plc (the "Company")
announces that as part of its 2024/2025
Save As You Earn share scheme (the "SAYE Scheme"),
which is open to all employees of the
Group, the Executive Directors named below have elected to
participate in the SAYE Scheme and have
been granted SAYE Scheme options as
follows:
Richard Fairman
722 SAYE scheme options
Robin Alfonso
700 SAYE scheme
options
Paul Higgs
722 SAYE
scheme options
Eligible employees were invited to
subscribe for options over the Company's ordinary shares of 0.2
pence each ("Ordinary Shares") with an exercise price of
847 pence per share, representing a
10% discount to the average closing middle
market price for the three dealing days prior to 1 November 2024,
being the invitation date.
In response to accepted invitations,
a total of 612,781 SAYE Scheme options over Ordinary Shares were
granted on 26 November 2024, equating to 0.86% of the current
issued ordinary share capital. Subject to the rules of the
SAYE Scheme, these options will be capable of exercise from the
maturity date on 1 January 2028.
The notification below, made in
accordance with the requirements of UK MAR, provides further
detail.
CVS Group plc
via
Camarco
Richard Fairman, CEO
Scott Morrison Group Company
Secretary
Peel Hunt LLP
(Nominated Adviser & Broker)
+44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark
/ Lalit Bose
Berenberg
(Joint
Broker)
+44 (0)20 3207 7800
Toby Flaux / Ben Wright / Ciaran Walsh / Milo
Bonser
Camarco (Financial
PR)
Geoffrey Pelham-Lane
+44 (0)7733 124
226
Ginny Pulbrook
+44 (0)7961 315 138
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
|
1
|
Details of the person discharging managerial responsibilities
/ person closely
associated
|
|
a)
|
Name
|
Richard Fairman
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Chief Executive Officer
|
|
b)
|
Initial notification
/Amendment
|
Initial Notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
CVS Group plc
|
|
b)
|
LEI
|
213800J41XDQ2NX48O05
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where
transactions have been conducted
|
|
a)
|
Description of the financial
instrument, type of instrument
Identification code
|
Options over Ordinary shares of 0.2
pence each
GB00B2863827
|
|
b)
|
Nature of the transaction
|
Grant of Options under the SAYE
Scheme.
|
|
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
Exercise price of 847p
|
722
|
|
|
d)
|
Aggregated information
- Aggregated
volume
- Price
|
|
|
e)
|
Date of the transaction
|
26
November 2024
|
|
f)
|
Place of the transaction
|
Off
market
|
|
1
|
Details of the person discharging managerial responsibilities
/ person closely
associated
|
|
a)
|
Name
|
Robin Alfonso
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Chief Financial Officer
|
|
b)
|
Initial notification
/Amendment
|
Initial Notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
CVS Group plc
|
|
b)
|
LEI
|
213800J41XDQ2NX48O05
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where
transactions have been conducted
|
|
a)
|
Description of the financial
instrument, type of instrument
Identification code
|
Options over Ordinary shares of 0.2
pence each
GB00B2863827
|
|
b)
|
Nature of the transaction
|
Grant of Options under the SAYE
Scheme.
|
|
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
Exercise price of 847p
|
700
|
|
|
d)
|
Aggregated information
- Aggregated
volume
- Price
|
|
|
e)
|
Date of the transaction
|
26
November 2024
|
|
f)
|
Place of the transaction
|
Off
market
|
|
1
|
Details of the person discharging managerial responsibilities
/ person closely
associated
|
|
a)
|
Name
|
Paul Higgs
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Chief Veterinary Officer &
Director
|
|
b)
|
Initial notification
/Amendment
|
Initial Notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
CVS Group plc
|
|
b)
|
LEI
|
213800J41XDQ2NX48O05
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where
transactions have been conducted
|
|
a)
|
Description of the financial
instrument, type of instrument
Identification code
|
Options over Ordinary shares of 0.2
pence each
GB00B2863827
|
|
b)
|
Nature of the transaction
|
Grant of Options under the SAYE
Scheme.
|
|
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
Exercise price of 847p
|
722
|
|
|
d)
|
Aggregated information
- Aggregated
volume
- Price
|
|
|
e)
|
Date of the transaction
|
26
November 2024
|
|
f)
|
Place of the transaction
|
Off
market
|